Cargando…
Integrated care in ovarian cancer “IgV Ovar”: results of a German pilot for higher quality in treatment of ovarian cancer
INTRODUCTION: Late-stage ovarian cancer patient’s survival depends on complete cytoreduction and chemotherapy. Complete cytoreduction is more often achieved in institutions with a case volume of >20 cases per year. The Integrated care program Ovar (IgV Ovar) was founded in 2005 and started recrui...
Autores principales: | Keyver-Paik, M.-D., Abramian, A., Domröse, C., Döser, A., Höller, T., Friedrich, M., Meier, W., Menn, K., Kuhn, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717158/ https://www.ncbi.nlm.nih.gov/pubmed/26498774 http://dx.doi.org/10.1007/s00432-015-2055-6 |
Ejemplares similares
-
The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
por: Delgado-Ortega, Laura, et al.
Publicado: (2018) -
Individual management of cervical cancer in pregnancy
por: Hecking, Thomas, et al.
Publicado: (2016) -
Ovaritis
por: Duncan, J. Matthews
Publicado: (1871) -
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
por: Ayub, Tiyasha H., et al.
Publicado: (2015) -
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial
por: Fumet, Jean-David, et al.
Publicado: (2022)